When a research peptide is labeled ≥99% pure, that figure comes from High-Performance Liquid Chromatography (HPLC) analysis — the industry-standard method for separating and quantifying the individual compounds present in a sample. In practice, it means that out of everything detected in the vial, at least 99% of the measured peak area corresponds to the target peptide, with the remaining fraction made up of synthesis byproducts, salts, or residual solvents.
Why Purity Affects Reproducibility
In any research setting, the biggest threat to reproducible results isn’t usually the experimental design — it’s variability in your reagents. A peptide sample with unpredictable impurity content can introduce confounding variables into cell assays, binding studies, or in-vivo models, making it difficult to attribute an observed effect to the peptide itself rather than a contaminant.
This is why every batch we produce is tested individually rather than relying on a single validation run for an entire production process. Synthesis conditions can drift subtly from batch to batch, and a testing regime that only spot-checks periodically can miss that drift entirely.
Reading a Certificate of Analysis
A proper Certificate of Analysis (COA) should show the chromatogram itself, not just a summary percentage. Look for a single dominant peak with minimal shoulder peaks, a stated testing method (HPLC, and ideally Mass Spectrometry for identity confirmation), and a batch or lot number that ties the certificate to the specific vial you received.
If a supplier can’t provide batch-specific documentation, that’s a signal to look elsewhere — purity claims without traceable testing data are not verifiable.
